REPROCELL

Our portfolio includes an extensive product catalog to support stem cell research and 3D bioengineered tissues, a commercial biorepository of ethically-sourced human tissue samples, extensive clinical networks across the USA and Europe that enable our contract research services in human ex vivo living tissues, and our capability to supply induced pluripotent stem cells (iPSCs) for both clinical stem cell and research stem cell applications.
We are also developing novel regenerative medicine therapies to treat neurodegenerative disease, based on our expertise in pluripotent stem cells and mesenchymal stem cells, and we are currently conducting clinical trials in Japan for the treatment of spinocerebellar ataxia. Our diagnostic services and clinical research services are offered across labs in Japan, USA, UK, and India.
Our expertise in patient recruitment, the logistics, and ethics of accessing human biospecimens and diagnostics is driving the development of new technologies to support biomarker research and precision medicine. Combined with our clinical laboratory facilities, these resources and know-how have positioned REPROCELL as a fully integrated partner for the life sciences industry, with clients across the globe.